{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:07:03Z","timestamp":1794406023633,"version":"4.9.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T.0115.24"],"award-info":[{"award-number":["T.0115.24"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T.0032.25"],"award-info":[{"award-number":["T.0032.25"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022434","name":"Walloon excellence in life sciences and biotechnology","doi-asserted-by":"publisher","award":["WELBIO-CR-2022A-02P"],"award-info":[{"award-number":["WELBIO-CR-2022A-02P"]}],"id":[{"id":"10.13039\/501100022434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02629-z","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:45:06Z","timestamp":1749188706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fecal Dysosmobacter spp. concentration is linked to plasma lipidome in insulin-resistant individuals with overweight, obesity and metabolic syndrome"],"prefix":"10.1186","volume":"24","author":[{"given":"Camille","family":"Petitfils","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Depommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie M.","family":"Delzenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Everard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice D.","family":"Cani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"3","key":"2629_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2629_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"E Kassi","year":"2011","unstructured":"Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9: 48.","journal-title":"BMC Med"},{"issue":"1","key":"2629_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","volume":"6","author":"PW Gilijamse","year":"2020","unstructured":"Gilijamse PW, Hartstra AV, Levin E, Wortelboer K, Serlie MJ, Ackermans MT, et al. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome. NPJ Biofilms Microbiomes. 2020;6(1):16.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"7","key":"2629_CR4","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103.","journal-title":"Nat Med"},{"issue":"3","key":"2629_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2020-323778","volume":"71","author":"T Le Roy","year":"2022","unstructured":"Le Roy T, Moens de Hase E, Van Hul M, Paquot A, Pelicaen R, R\u00e9gnier M, et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut. 2022;71(3):534\u201343.","journal-title":"Gut."},{"issue":"9","key":"2629_CR6","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1099\/ijsem.0.003547","volume":"70","author":"T Le Roy","year":"2020","unstructured":"Le Roy T, Van der Smissen P, Paquot A, Delzenne N, Muccioli GG, Collet JF, et al. Dysosmobacter welbionis gen. nov., sp. nov., isolated from human faeces and emended description of the genus Oscillibacter. Int J Syst Evol Microbiol. 2020;70(9):4851\u20138.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"2","key":"2629_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00125-023-06032-0","volume":"67","author":"E Moens de Hase","year":"2024","unstructured":"Moens de Hase E, Neyrinck AM, Rodriguez J, Cnop M, Paquot N, Thissen JP, et al. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention. Diabetologia. 2024;67(2):333\u201345.","journal-title":"Diabetologia"},{"issue":"7","key":"2629_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/metabo11070418","volume":"11","author":"AV Aderemi","year":"2021","unstructured":"Aderemi AV, Ayeleso AO, Oyedapo OO, Mukwevho E. Metabolomics: a scoping review of its role as a tool for disease biomarker discovery in selected non-communicable diseases. Metabolites. 2021;11(7):418.","journal-title":"Metabolites"},{"issue":"7","key":"2629_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2629_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40200-021-00917-w","volume":"21","author":"M Payab","year":"2022","unstructured":"Payab M, Tayanloo-Beik A, Falahzadeh K, Mousavi M, Salehi S, Djalalinia S, et al. Metabolomics prospect of obesity and metabolic syndrome; a systematic review. J Diabetes Metab Disord. 2022;21(1):889\u2013917.","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"2629_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11306-019-1553-y","volume":"15","author":"OD Rangel-Huerta","year":"2019","unstructured":"Rangel-Huerta OD, Pastor-Villaescusa B, Gil A. Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies. Metabolomics. 2019;15(6):93.","journal-title":"Metabolomics"},{"issue":"1","key":"2629_CR12","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","volume":"10","author":"A Visconti","year":"2019","unstructured":"Visconti A, Le Roy CI, Rosa F, Rossi N, Martin TC, Mohney RP, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505.","journal-title":"Nat Commun"},{"issue":"10","key":"2629_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski T, Rappaport N, Earls JC, Magis AT, Manor O, Lovejoy J, et al. Blood metabolome predicts gut microbiome alpha-diversity in humans. Nat Biotechnol. 2019;37(10):1217\u201328.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2629_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27(2):321\u201332.","journal-title":"Nat Med"},{"issue":"7","key":"2629_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1017\/S0007114520004870","volume":"126","author":"V Partula","year":"2021","unstructured":"Partula V, Deschasaux-Tanguy M, Mondot S, Victor-Bala A, Bouchemal N, L\u00e9cuyer L, et al. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Int\u00e9rieur population of healthy adults. Br J Nutr. 2021;126(7):982\u201392.","journal-title":"Br J Nutr"},{"issue":"1","key":"2629_CR16","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-022-33050-0","volume":"13","author":"KF Dekkers","year":"2022","unstructured":"Dekkers KF, Sayols-Baixeras S, Baldanzi G, Nowak C, Hammar U, Nguyen D, et al. An online atlas of human plasma metabolite signatures of gut microbiome composition. Nat Commun. 2022;13(1):5370.","journal-title":"Nat Commun"},{"key":"2629_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114295","volume":"160","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen R, Zhang D, Qi S, Liu Y. Metabolite interactions between host and microbiota during health and disease: which feeds the other? Biomed Pharmacother. 2023;160: 114295.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2629_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/cells10010071","volume":"10","author":"C Depommier","year":"2021","unstructured":"Depommier C, Flamand N, Pelicaen R, Maiter D, Thissen JP, Loumaye A, et al. Linking the Endocannabinoidome with specific metabolic parameters in an overweight and insulin-resistant population: from multivariate exploratory analysis to univariate analysis and construction of predictive models. Cells. 2021;10(1):71.","journal-title":"Cells"},{"issue":"1","key":"2629_CR19","doi-asserted-by":"publisher","first-page":"1994270","DOI":"10.1080\/19490976.2021.1994270","volume":"13","author":"C Depommier","year":"2021","unstructured":"Depommier C, Everard A, Druart C, Maiter D, Thissen JP, Loumaye A, et al. Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome. Gut Microbes. 2021;13(1):1994270.","journal-title":"Gut Microbes"},{"issue":"6","key":"2629_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"4","key":"2629_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2337\/dc17-1827","volume":"41","author":"JM Dennis","year":"2018","unstructured":"Dennis JM, Shields BM, Hill AV, Knight BA, McDonald TJ, Rodgers LR, et al. Precision medicine in type 2 diabetes: clinical markers of insulin resistance are associated with altered short- and long-term glycemic response to DPP-4 inhibitor therapy. Diabetes Care. 2018;41(4):705\u201312.","journal-title":"Diabetes Care"},{"issue":"10","key":"2629_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/metabo9100210","volume":"9","author":"H Babu","year":"2019","unstructured":"Babu H, Sperk M, Ambikan AT, Rachel G, Viswanathan VK, Tripathy SP, et al. Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy. Metabolites. 2019;9(10):210.","journal-title":"Metabolites"},{"key":"2629_CR23","doi-asserted-by":"publisher","unstructured":"Depommier C, Vitale RM, Iannotti FA, Silvestri C, Flamand N, Druart C, et al. Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPAR\u03b1 Agonists. Cells. 2021 Jan 19;10(1):185. https:\/\/doi.org\/10.3390\/cells10010185. PMID: 33477821; PMCID: PMC7832901.","DOI":"10.3390\/cells10010185"},{"key":"2629_CR24","unstructured":"William R. Procedures for psychological, psychometric, and personality research. Package \u2018pscyh; 2021."},{"key":"2629_CR25","unstructured":"Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla J, et al. corrplot: visualization of a correlation matrix (0.92). WWW document] URL https:\/\/github.com\/taiyun\/corrplot. Accessed 23 Sep 2021."},{"issue":"19","key":"2629_CR26","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, Gu L, Eils R, Schlesner M, Brors B. Circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30(19):2811\u20132.","journal-title":"Bioinformatics"},{"issue":"10","key":"2629_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100437","volume":"64","author":"E Moens De Hase","year":"2023","unstructured":"Moens De Hase E, Petitfils C, Alhouayek M, Depommier C, Le Faouder P, Delzenne NM, et al. Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids. Journal of Lipid Research. 2023;64(10): 100437.","journal-title":"Journal of Lipid Research."},{"issue":"8","key":"2629_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082590","volume":"13","author":"GC Henderson","year":"2021","unstructured":"Henderson GC. Plasma free fatty acid concentration as a modifiable risk factor for metabolic disease. Nutrients. 2021;13(8): 2590.","journal-title":"Nutrients"},{"issue":"4","key":"2629_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740\u201356.","journal-title":"Cell Metab"},{"issue":"4","key":"2629_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/oby.21448","volume":"24","author":"KT Tonks","year":"2016","unstructured":"Tonks KT, Coster AC, Christopher MJ, Chaudhuri R, Xu A, Gagnon-Bartsch J, et al. Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans. Obesity (Silver Spring, Md). 2016;24(4):908\u201316.","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"1","key":"2629_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12863-017-0515-5","volume":"18","author":"H Kulkarni","year":"2017","unstructured":"Kulkarni H, Mamtani M, Wong G, Weir JM, Barlow CK, Dyer TD, et al. Genetic correlation of the plasma lipidome with type 2 diabetes, prediabetes and insulin resistance in Mexican American families. BMC Genet. 2017;18(1):48.","journal-title":"BMC Genet"},{"issue":"Suppl 1","key":"2629_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/dom.13008","volume":"19","author":"P Poursharifi","year":"2017","unstructured":"Poursharifi P, Madiraju SRM, Prentki M. Monoacylglycerol signalling and ABHD6 in health and disease. Diabetes Obes Metab. 2017;19(Suppl 1):76\u201389.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2629_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2337\/dc19-2533","volume":"43","author":"J Vangipurapu","year":"2020","unstructured":"Vangipurapu J, Fernandes Silva L, Kuulasmaa T, Smith U, Laakso M. Microbiota-related metabolites and the risk of type 2 diabetes. Diabetes Care. 2020;43(6):1319\u201325.","journal-title":"Diabetes Care"},{"issue":"2","key":"2629_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/db21-0490","volume":"71","author":"NA Yousri","year":"2022","unstructured":"Yousri NA, Suhre K, Yassin E, Al-Shakaki A, Robay A, Elshafei M, et al. Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia. Diabetes. 2022;71(2):184\u2013205.","journal-title":"Diabetes"},{"issue":"1","key":"2629_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/msb.2010.46","volume":"6","author":"GG Muccioli","year":"2010","unstructured":"Muccioli GG, Naslain D, B\u00e4ckhed F, Reigstad CS, Lambert DM, Delzenne NM, et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010;6(1):392.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"2629_CR36","doi-asserted-by":"publisher","first-page":"15645","DOI":"10.1038\/s41598-017-15154-6","volume":"7","author":"P Mehrpouya-Bahrami","year":"2017","unstructured":"Mehrpouya-Bahrami P, Chitrala KN, Ganewatta MS, Tang C, Murphy EA, Enos RT, et al. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep. 2017;7(1):15645.","journal-title":"Sci Rep"},{"issue":"8","key":"2629_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082164","volume":"11","author":"K Naja","year":"2023","unstructured":"Naja K, Anwardeen N, Al-Hariri M, Al Thani AA, Elrayess MA. Pharmacometabolomic approach to investigate the response to metformin in patients with type 2 diabetes: a cross-sectional study. Biomedicines. 2023;11(8): 2164.","journal-title":"Biomedicines"},{"key":"2629_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00087","volume":"9","author":"Y Audet-Delage","year":"2018","unstructured":"Audet-Delage Y, Villeneuve L, Gr\u00e9goire J, Plante M, Guillemette C. Identification of metabolomic biomarkers for endometrial cancer and its recurrence after surgery in postmenopausal women. Front Endocrinol. 2018;9: 87.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2629_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/jth.13937","volume":"16","author":"OA Zeleznik","year":"2018","unstructured":"Zeleznik OA, Poole EM, Lindstrom S, Kraft P, Van Hylckama VA, Lasky-Su JA, et al. Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes. J Thromb Haemost. 2018;16(3):500\u20137.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2629_CR40","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1021\/pr5009898","volume":"14","author":"PA Vorkas","year":"2015","unstructured":"Vorkas PA, Shalhoub J, Isaac G, Want EJ, Nicholson JK, Holmes E, et al. Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis. J Proteome Res. 2015;14(3):1389\u201399.","journal-title":"J Proteome Res"},{"issue":"1","key":"2629_CR41","doi-asserted-by":"publisher","first-page":"204589401989055","DOI":"10.1177\/2045894019890553","volume":"10","author":"GA Heresi","year":"2020","unstructured":"Heresi GA, Mey JT, Bartholomew JR, Haddadin IS, Tonelli AR, Dweik RA, et al. Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 2020;10(1):2045894019890553.","journal-title":"Pulmonary Circulation"},{"issue":"1","key":"2629_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10010034","volume":"10","author":"A Germain","year":"2020","unstructured":"Germain A, Barupal DK, Levine SM, Hanson MR. Comprehensive circulatory metabolomics in ME\/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites. 2020;10(1): 34.","journal-title":"Metabolites"},{"key":"2629_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.908534","volume":"9","author":"JW Kang","year":"2022","unstructured":"Kang JW, Tang X, Walton CJ, Brown MJ, Brewer RA, Maddela RL, et al. Multi-omic analyses reveal bifidogenic effect and metabolomic shifts in healthy human cohort supplemented with a prebiotic dietary fiber blend. Front Nutr. 2022;9: 908534.","journal-title":"Front Nutr"},{"issue":"3","key":"2629_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15761\/IFNM.1000252","volume":"6","author":"I Zarei","year":"2019","unstructured":"Zarei I, Oppel RC, Borresen EC, Brown RJ, Ryan EP. Modulation of plasma and urine metabolome in colorectal cancer survivors consuming rice bran. Integrative Food, Nutrition and Metabolism. 2019;6(3):10.","journal-title":"Integrative Food, Nutrition and Metabolism"},{"issue":"20","key":"2629_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300044","volume":"67","author":"C Li","year":"2023","unstructured":"Li C, Bundy JD, Tian L, Zhang R, Chen J, Kelly TN, et al. Examination of serum metabolome altered by dietary carbohydrate, milk protein, and soy protein interventions identified novel metabolites associated with blood pressure: the ProBP trial. Mol Nutr Food Res. 2023;67(20): e2300044.","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"2629_CR46","doi-asserted-by":"publisher","first-page":"nzab101","DOI":"10.1093\/cdn\/nzab101","volume":"5","author":"LE Zambrana","year":"2021","unstructured":"Zambrana LE, Weber AM, Borresen EC, Zarei I, Perez J, Perez C, et al. Daily rice bran consumption for 6 months influences serum glucagon-like peptide 2 and metabolite profiles without differences in trace elements and heavy metals in weaning nicaraguan infants at 12 months of age. Current Developments in Nutrition. 2021;5(9):nzab101.","journal-title":"Current Developments in Nutrition"},{"key":"2629_CR47","unstructured":"Hunt R, de Mortemer Taveau R. The effects of a number of derivatives of choline and analogous compounds on the blood-pressure. US Government Printing Office; 1911."},{"issue":"2","key":"2629_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020283","volume":"10","author":"MG Akimov","year":"2020","unstructured":"Akimov MG, Kudryavtsev DS, Kryukova EV, Fomina-Ageeva EV, Zakharov SS, Gretskaya NM, et al. Arachidonoylcholine and other unsaturated long-chain acylcholines are endogenous modulators of the acetylcholine signaling system. Biomolecules. 2020;10(2): 283.","journal-title":"Biomolecules"},{"issue":"6","key":"2629_CR49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/clinchem\/29.6.1031","volume":"29","author":"R Jain","year":"1983","unstructured":"Jain R, Kutty KM, Huang SN, Kean K. Pseudocholinesterase\/high-density lipoprotein cholesterol ratio in serum of normal persons and of hyperlipoproteinemics. Clin Chem. 1983;29(6):1031\u20133.","journal-title":"Clin Chem"},{"issue":"19","key":"2629_CR50","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","volume":"46","author":"T Iwasaki","year":"2007","unstructured":"Iwasaki T, Yoneda M, Nakajima A, Terauchi Y. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Intern Med. 2007;46(19):1633\u20139.","journal-title":"Intern Med"},{"issue":"9","key":"2629_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","volume":"38","author":"EW Randell","year":"2005","unstructured":"Randell EW, Mathews MS, Zhang H, Seraj JS, Sun G. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin Biochem. 2005;38(9):799\u2013805.","journal-title":"Clin Biochem"},{"issue":"11","key":"2629_CR52","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1210\/en.2004-0569","volume":"145","author":"C De Vriese","year":"2004","unstructured":"De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology. 2004;145(11):4997\u20135005.","journal-title":"Endocrinology"},{"issue":"5","key":"2629_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.plipres.2009.05.001","volume":"48","author":"M Lafontan","year":"2009","unstructured":"Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res. 2009;48(5):275\u201397.","journal-title":"Prog Lipid Res"},{"issue":"5","key":"2629_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.363","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm. 2023;4(5): e363.","journal-title":"MedComm"},{"issue":"11","key":"2629_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113285","volume":"19","author":"T Sonnweber","year":"2018","unstructured":"Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic acid metabolites in cardiovascular and metabolic diseases. Int J Mol Sci. 2018;19(11): 3285.","journal-title":"Int J Mol Sci"},{"key":"2629_CR56","unstructured":"Blood exams referential Li\u00e8ge CHU - Urea. Available from: https:\/\/www.chu.ulg.ac.be\/jcms\/c_498724\/fr\/uree-sang."},{"issue":"5","key":"2629_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1159\/000111171","volume":"51","author":"JE Galgani","year":"2007","unstructured":"Galgani JE, Aguirre CA, Uauy RD, D\u00edaz EO. Plasma arachidonic acid influences insulin-stimulated glucose uptake in healthy adult women. Ann Nutr Metab. 2007;51(5):482\u20139.","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"2629_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032116","volume":"24","author":"A-M Mustonen","year":"2023","unstructured":"Mustonen A-M, Nieminen P. Dihomo-\u03b3-Linolenic Acid (20:3n\u20136)\u2014metabolism, derivatives, and potential significance in chronic inflammation. Int J Mol Sci. 2023;24(3): 2116.","journal-title":"Int J Mol Sci"},{"key":"2629_CR59","doi-asserted-by":"publisher","unstructured":"Das UN. Cell Membrane Theory of Senescence and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications. Biomolecules. 2021;11(2):241. https:\/\/doi.org\/10.3390\/biom11020241. PMID: 33567774; PMCID: PMC7914625.","DOI":"10.3390\/biom11020241"},{"issue":"1","key":"2629_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","volume":"22","author":"E Borgeson","year":"2015","unstructured":"Borgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, et al. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease. Cell Metab. 2015;22(1):125\u201337.","journal-title":"Cell Metab"},{"issue":"3","key":"2629_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molmet.2014.01.011","volume":"3","author":"PJ Larsen","year":"2014","unstructured":"Larsen PJ, Tennagels N. On ceramides, other sphingolipids and impaired glucose homeostasis. Molecular Metabolism. 2014;3(3):252\u201360.","journal-title":"Molecular Metabolism"},{"issue":"9","key":"2629_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074341","volume":"8","author":"PJ Meikle","year":"2013","unstructured":"Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, MacIntosh GL, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One. 2013;8(9): e74341.","journal-title":"PLoS One"},{"issue":"1","key":"2629_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006;45(1):42\u201372.","journal-title":"Prog Lipid Res"},{"issue":"11","key":"2629_CR64","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/oby.2011.107","volume":"19","author":"H Huang","year":"2011","unstructured":"Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR, et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring). 2011;19(11):2235\u201340.","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"2629_CR65","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/db06-0330","volume":"55","author":"F Samad","year":"2006","unstructured":"Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes. 2006;55(9):2579\u201387.","journal-title":"Diabetes"},{"issue":"10","key":"2629_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2014.38","volume":"4","author":"H Hanamatsu","year":"2014","unstructured":"Hanamatsu H, Ohnishi S, Sakai S, Yuyama K, Mitsutake S, Takeda H, et al. Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. Nutr Diabetes. 2014;4(10): e141.","journal-title":"Nutr Diabetes"},{"issue":"10","key":"2629_CR67","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1194\/jlr.P035808","volume":"54","author":"JM Weir","year":"2013","unstructured":"Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res. 2013;54(10):2898\u2013908.","journal-title":"J Lipid Res"},{"issue":"2","key":"2629_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2337\/db12-0686","volume":"62","author":"J Boon","year":"2013","unstructured":"Boon J, Hoy AJ, Stark R, Brown RD, Meex RC, Henstridge DC, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes. 2013;62(2):401\u201310.","journal-title":"Diabetes"},{"issue":"12","key":"2629_CR69","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1007\/s00125-009-1482-9","volume":"52","author":"VD de Mello","year":"2009","unstructured":"de Mello VD, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppanen-Laakso T, et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia. 2009;52(12):2612\u20135.","journal-title":"Diabetologia"},{"issue":"9","key":"2629_CR70","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11745-006-5041-6","volume":"41","author":"I Ichi","year":"2006","unstructured":"Ichi I, Nakahara K, Miyashita Y, Hidaka A, Kutsukake S, Inoue K, et al. Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids. 2006;41(9):859\u201363.","journal-title":"Lipids"},{"issue":"4","key":"2629_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1210\/er.2007-0025","volume":"29","author":"WL Holland","year":"2008","unstructured":"Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008;29(4):381\u2013402.","journal-title":"Endocr Rev"},{"issue":"10","key":"2629_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164173","volume":"11","author":"S Kopprasch","year":"2016","unstructured":"Kopprasch S, Dheban S, Schuhmann K, Xu A, Schulte KM, Simeonovic CJ, et al. Detection of Independent associations of plasma lipidomic parameters with insulin sensitivity indices using data mining methodology. PLoS One. 2016;11(10): e0164173.","journal-title":"PLoS One"},{"issue":"3","key":"2629_CR73","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.numecd.2023.10.026","volume":"34","author":"JC Bae","year":"2024","unstructured":"Bae JC, Wander PL, Lemaitre RN, Fretts AM, Sitlani CM, Bui HH, et al. Associations of plasma sphingolipids with measures of insulin sensitivity, \u03b2-cell function, and incident diabetes in Japanese Americans. Nutr Metab Cardiovasc Dis. 2024;34(3):633\u201341.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"2629_CR74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009;58(2):337\u201343.","journal-title":"Diabetes"},{"issue":"4","key":"2629_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/nu12040981","volume":"12","author":"L Chen","year":"2020","unstructured":"Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. Vitamin D3 supplementation increases long-chain ceramide levels in overweight\/obese African Americans: a post-hoc analysis of a randomized controlled trial. Nutrients. 2020;12(4): 981.","journal-title":"Nutrients"},{"issue":"12","key":"2629_CR76","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2337\/dc18-0840","volume":"41","author":"C Razquin","year":"2018","unstructured":"Razquin C, Toledo E, Clish CB, Ruiz-Canela M, Dennis C, Corella D, et al. Plasma lipidomic profiling and risk of type 2 diabetes in the PREDIMED trial. Diabetes Care. 2018;41(12):2617\u201324.","journal-title":"Diabetes Care"},{"key":"2629_CR77","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2017.10.026","volume":"253","author":"C Razquin","year":"2018","unstructured":"Razquin C, Liang L, Toledo E, Clish CB, Ruiz-Canela M, Zheng Y, et al. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: a case-cohort study. Int J Cardiol. 2018;253:126\u201332.","journal-title":"Int J Cardiol"},{"issue":"14","key":"2629_CR78","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.3390\/ijerph19148272","volume":"19","author":"E Jung","year":"2022","unstructured":"Jung E, Kong SY, Ro YS, Ryu HH, Shin SD. Serum cholesterol levels and risk of cardiovascular death: a systematic review and a dose-response meta-analysis of prospective cohort studies. Int J Environ Res Public Health. 2022;19(14):8272.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"2629_CR79","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","volume":"187","author":"C Li","year":"2024","unstructured":"Li C, Stra\u017ear M, Mohamed AMT, Pacheco JA, Walker RL, Lebar T, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. 2024;187(8):1834-52.e19.","journal-title":"Cell"},{"key":"2629_CR80","doi-asserted-by":"publisher","first-page":"1065665","DOI":"10.3389\/fendo.2022.1065665","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang J, Wang M, Yang D, Yan H, Wang Z, Yan D, et al. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients. Frontiers in Endocrinology. 2023;13:1065665.","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"2629_CR81","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1210\/jc.2015-3525","volume":"101","author":"S Rauschert","year":"2016","unstructured":"Rauschert S, Uhl O, Koletzko B, Kirchberg F, Mori TA, Huang R-C, et al. Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults. J Clin Endocrinol Metab. 2016;101(3):871\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2629_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081205","volume":"16","author":"S-J Pang","year":"2024","unstructured":"Pang S-J, Liu T-T, Pan J-C, Man Q-Q, Song S, Zhang J. The association between the plasma phospholipid profile and insulin resistance: a population-based cross-section study from the China adult chronic disease and nutrition surveillance. Nutrients. 2024;16(8): 1205.","journal-title":"Nutrients"},{"issue":"1","key":"2629_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085724","volume":"9","author":"A Sigruener","year":"2014","unstructured":"Sigruener A, Kleber ME, Heimerl S, Liebisch G, Schmitz G, Maerz W. Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. PLoS One. 2014;9(1): e85724.","journal-title":"PLoS One"},{"issue":"21","key":"2629_CR84","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","volume":"134","author":"ZH Alshehry","year":"2016","unstructured":"Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, et al. Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus. Circulation. 2016;134(21):1637\u201350.","journal-title":"Circulation"},{"issue":"23","key":"2629_CR85","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00018-006-6155-y","volume":"63","author":"E Birgbauer","year":"2006","unstructured":"Birgbauer E, Chun J. New developments in the biological functions of lysophospholipids. Cell Mol Life Sci. 2006;63(23):2695\u2013701.","journal-title":"Cell Mol Life Sci"},{"key":"2629_CR86","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.biochem.73.011303.073731","volume":"73","author":"I Ishii","year":"2004","unstructured":"Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321\u201354.","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"2629_CR87","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/molecules15031354","volume":"15","author":"P D'Arrigo","year":"2010","unstructured":"D\u2019Arrigo P, Servi S. Synthesis of lysophospholipids. Molecules. 2010;15(3):1354\u201377.","journal-title":"Molecules"},{"issue":"5","key":"2629_CR88","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2265.2011.04244.x","volume":"76","author":"CY Ha","year":"2012","unstructured":"Ha CY, Kim JY, Paik JK, Kim OY, Paik Y-H, Lee EJ, et al. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol. 2012;76(5):674\u201382.","journal-title":"Clin Endocrinol"},{"issue":"12","key":"2629_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121851","volume":"10","author":"A Kuang","year":"2018","unstructured":"Kuang A, Erlund I, Herder C, Westerhuis JA, Tuomilehto J, Cornelis MC. Lipidomic response to coffee consumption. Nutrients. 2018;10(12): 1851.","journal-title":"Nutrients"},{"issue":"3","key":"2629_CR90","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/ijms22031500","volume":"22","author":"S Dommel","year":"2021","unstructured":"Dommel S, Bluher M. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state? Int J Mol Sci. 2021;22(3):1500.","journal-title":"Int J Mol Sci"},{"key":"2629_CR91","doi-asserted-by":"publisher","first-page":"326580","DOI":"10.1155\/2010\/326580","volume":"2010","author":"A Rull","year":"2010","unstructured":"Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm. 2010;2010:326580.","journal-title":"Mediators Inflamm"},{"issue":"7","key":"2629_CR92","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1210\/clinem\/dgac198","volume":"107","author":"Q Qiao","year":"2022","unstructured":"Qiao Q, Bouwman FG, van Baak MA, Roumans NJT, Vink RG, Mariman ECM. Plasma levels of triglycerides and IL-6 are associated with weight regain and fat mass expansion. J Clin Endocrinol Metab. 2022;107(7):1920\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2629_CR93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2018.04.020","volume":"110","author":"AMB Menezes","year":"2018","unstructured":"Menezes AMB, Oliveira PD, Wehrmeister FC, Goncalves H, Assuncao MCF, Tovo-Rodrigues L, et al. Association between interleukin-6, C-reactive protein and adiponectin with adiposity: findings from the 1993 pelotas (Brazil) birth cohort at 18 and 22 years. Cytokine. 2018;110:44\u201351.","journal-title":"Cytokine"},{"issue":"7","key":"2629_CR94","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/oby.2001.54","volume":"9","author":"B Vozarova","year":"2001","unstructured":"Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 2001;9(7):414\u20137.","journal-title":"Obes Res"},{"issue":"9","key":"2629_CR95","first-page":"3338","volume":"85","author":"JP Bastard","year":"2000","unstructured":"Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85(9):3338\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2629_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/CCLM.2010.052","volume":"48","author":"M Webber","year":"2010","unstructured":"Webber M, Krishnan A, Thomas NG, Cheung BM. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005\u20132006. Clin Chem Lab Med. 2010;48(2):167\u201373.","journal-title":"Clin Chem Lab Med"},{"key":"2629_CR97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cca.2019.10.015","volume":"500","author":"JH Kim","year":"2020","unstructured":"Kim JH, Lee HS, Park HM, Lee YJ. Serum alkaline phosphatase level is positively associated with metabolic syndrome: a nationwide population-based study. Clin Chim Acta. 2020;500:189\u201394.","journal-title":"Clin Chim Acta"},{"key":"2629_CR98","doi-asserted-by":"publisher","unstructured":"Sigvardsen CM, Richter MM, Engelbeen S, Kleinert M, Richter EA. GDF15 is still a mystery hormone. Trends Endocrinol Metab. 2024:S1043-2760(24)00254-6. https:\/\/doi.org\/10.1016\/j.tem.2024.09.002. Epub ahead of print. PMID: 39472228.","DOI":"10.1016\/j.tem.2024.09.002"},{"issue":"1","key":"2629_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","volume":"26","author":"K Huynh","year":"2019","unstructured":"Huynh K, Barlow CK, Jayawardana KS, Weir JM, Mellett NA, Cinel M, et al. High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors. Cell Chem Biol. 2019;26(1):71-84.e4.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"2629_CR100","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/obr.12475","volume":"18","author":"A Mika","year":"2017","unstructured":"Mika A, Sledzinski T. Alterations of specific lipid groups in serum of obese humans: a review. Obes Rev. 2017;18(2):247\u201372.","journal-title":"Obes Rev"},{"issue":"2","key":"2629_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3945\/ajcn.116.130872","volume":"104","author":"JM del Bas","year":"2016","unstructured":"del Bas JM, Caimari A, Rodriguez-Naranjo MI, Childs CE, Paras Chavez C, West AL, et al. Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n\u20133 polyunsaturated fatty acids in a randomized controlled trial12. Am J Clin Nutr. 2016;104(2):266\u201379.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2629_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020326","volume":"11","author":"P Pik\u00f3","year":"2021","unstructured":"Pik\u00f3 P, P\u00e1l L, Sz\u0171cs S, K\u00f3sa Z, S\u00e1ndor J, \u00c1d\u00e1ny R. Obesity-related changes in human plasma lipidome determined by the lipidyzer platform. Biomolecules. 2021;11(2): 326.","journal-title":"Biomolecules"},{"issue":"7","key":"2629_CR103","doi-asserted-by":"publisher","first-page":"e2200568","DOI":"10.1002\/mnfr.202200568","volume":"67","author":"P Bellot","year":"2023","unstructured":"Bellot P, Moia MN, Reis BZ, Pedrosa LFC, Tasic L, Barbosa F Jr, et al. Are phosphatidylcholine and lysophosphatidylcholine body levels potentially reliable biomarkers in obesity? A review of human studies. Mol Nutr Food Res. 2023;67(7):e2200568.","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"2629_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041456","volume":"7","author":"MN Barber","year":"2012","unstructured":"Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA, et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One. 2012;7(7): e41456.","journal-title":"PLoS One"},{"issue":"7","key":"2629_CR105","doi-asserted-by":"publisher","first-page":"587","DOI":"10.14348\/molcells.2015.0126","volume":"38","author":"S Park","year":"2015","unstructured":"Park S, Sadanala KC, Kim E-K. A metabolomic approach to understanding the metabolic link between obesity and diabetes. Mol Cells. 2015;38(7):587\u201396.","journal-title":"Mol Cells"},{"issue":"1","key":"2629_CR106","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","volume":"8","author":"R Wang-Sattler","year":"2012","unstructured":"Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012;8(1):615.","journal-title":"Mol Syst Biol"},{"issue":"5","key":"2629_CR107","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db12-0707","volume":"62","author":"E Ferrannini","year":"2013","unstructured":"Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam K-P, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. 2013;62(5):1730\u20137.","journal-title":"Diabetes"},{"key":"2629_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2017.08.014","volume":"78","author":"T Suvitaival","year":"2018","unstructured":"Suvitaival T, Bondia-Pons I, Yetukuri L, P\u00f6h\u00f6 P, Nolan JJ, Hy\u00f6tyl\u00e4inen T, et al. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men. Metabolism. 2018;78:1\u201312.","journal-title":"Metabolism"},{"issue":"4","key":"2629_CR109","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","volume":"326","author":"T Soga","year":"2005","unstructured":"Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun. 2005;326(4):744\u201351.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2629_CR110","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","volume":"56","author":"M Ore\u0161i\u010d","year":"2013","unstructured":"Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia. 2013;56(10):2266\u201374.","journal-title":"Diabetologia"},{"issue":"1","key":"2629_CR111","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-016-0552-3","volume":"14","author":"T K\u00fchn","year":"2016","unstructured":"K\u00fchn T, Floegel A, Sookthai D, Johnson T, Rolle-Kampczyk U, Otto W, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016;14(1):13.","journal-title":"BMC Med"},{"key":"2629_CR112","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.talanta.2015.10.070","volume":"148","author":"B Garc\u00eda-Fontana","year":"2016","unstructured":"Garc\u00eda-Fontana B, Morales-Santana S, D\u00edaz Navarro C, Rozas-Moreno P, Genilloud O, Vicente P\u00e9rez F, et al. Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study. Talanta. 2016;148:135\u201343.","journal-title":"Talanta"},{"issue":"12","key":"2629_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015234","volume":"5","author":"O Fiehn","year":"2010","unstructured":"Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010;5(12): e15234.","journal-title":"PLoS One"},{"key":"2629_CR114","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.aca.2020.06.017","volume":"1128","author":"T Xia","year":"2020","unstructured":"Xia T, Ren H, Zhang W, Xia Y. Lipidome-wide characterization of phosphatidylinositols and phosphatidylglycerols on C=C location level. Anal Chim Acta. 2020;1128:107\u201315.","journal-title":"Anal Chim Acta"},{"issue":"8","key":"2629_CR115","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1021\/acs.jproteome.9b00249","volume":"18","author":"S Anjos","year":"2019","unstructured":"Anjos S, Feiteira E, Cerveira F, Melo T, Reboredo A, Colombo S, et al. Lipidomics reveals similar changes in serum phospholipid signatures of overweight and obese pediatric subjects. J Proteome Res. 2019;18(8):3174\u201383.","journal-title":"J Proteome Res"},{"issue":"1","key":"2629_CR116","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42003-024-06298-z","volume":"7","author":"R Aisyah","year":"2024","unstructured":"Aisyah R, Ohshima N, Watanabe D, Nakagawa Y, Sakuma T, Nitschke F, et al. GDE5\/Gpcpd1 activity determines phosphatidylcholine composition in skeletal muscle and regulates contractile force in mice. Commun Biol. 2024;7(1):604.","journal-title":"Commun Biol"},{"issue":"17","key":"2629_CR117","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.3390\/jcm13175152","volume":"13","author":"RJ Shaw","year":"2024","unstructured":"Shaw RJ, Abrams ST, Badu S, Toh CH, Dutt T. The highs and lows of ADAMTS13 activity. J Clin Med. 2024;13(17):5152.","journal-title":"J Clin Med"},{"issue":"24","key":"2629_CR118","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1113\/JP287461","volume":"602","author":"JJ Holst","year":"2024","unstructured":"Holst JJ. Annual Prize Lecture 2024: endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes. J Physiol. 2024;602(24):6613\u201329.","journal-title":"J Physiol"},{"issue":"3","key":"2629_CR119","doi-asserted-by":"publisher","first-page":"001315","DOI":"10.1099\/mic.0.001315","volume":"169","author":"E Ryan","year":"2023","unstructured":"Ryan E, Joyce SA, Clarke DJ. Membrane lipids from gut microbiome-associated bacteria as structural and signalling molecules. Microbiology. 2023;169(3):001315.","journal-title":"Microbiology"},{"issue":"1","key":"2629_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010055","volume":"11","author":"S Lamichhane","year":"2021","unstructured":"Lamichhane S, Sen P, Alves MA, Ribeiro HC, Raunioniemi P, Hy\u00f6tyl\u00e4inen T, et al. Linking gut microbiome and lipid metabolism: moving beyond associations. Metabolites. 2021;11(1): 55.","journal-title":"Metabolites"},{"issue":"3\u20134","key":"2629_CR121","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.plipres.2009.03.003","volume":"48","author":"T Rezanka","year":"2009","unstructured":"Rezanka T, Sigler K. Odd-numbered very-long-chain fatty acids from the microbial, animal and plant kingdoms. Prog Lipid Res. 2009;48(3\u20134):206\u201338.","journal-title":"Prog Lipid Res"},{"issue":"2","key":"2629_CR122","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","volume":"31","author":"EM Brown","year":"2023","unstructured":"Brown EM, Clardy J, Xavier RJ. Gut microbiome lipid metabolism and its impact on host physiology. Cell Host Microbe. 2023;31(2):173\u201386.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"2629_CR123","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.bbalip.2016.10.007","volume":"1862","author":"IM L\u00f3pez-Lara","year":"2017","unstructured":"L\u00f3pez-Lara IM, Geiger O. Bacterial lipid diversity. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids. 2017;1862(11):1287\u201399.","journal-title":"Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids"},{"issue":"10","key":"2629_CR124","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1039\/D3SC04523D","volume":"15","author":"TH Lee","year":"2024","unstructured":"Lee TH, Charchar P, Separovic F, Reid GE, Yarovsky I, Aguilar MI. The intricate link between membrane lipid structure and composition and membrane structural properties in bacterial membranes. Chemical Science. 2024;15(10):3408\u201327.","journal-title":"Chemical Science"},{"key":"2629_CR125","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-319-50430-8_8","volume-title":"Biogenesis of fatty acids, lipids and membranes","author":"O Geiger","year":"2019","unstructured":"Geiger O, Sohlenkamp C, L\u00f3pez-Lara IM. Formation of bacterial glycerol-based membrane lipids: pathways, enzymes, and reactions. In: Geiger O, editor. Biogenesis of fatty acids, lipids and membranes. Cham: Springer International Publishing; 2019. p. 87\u2013107."},{"issue":"2","key":"2629_CR126","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/mi.2017.58","volume":"11","author":"BP Ganesh","year":"2018","unstructured":"Ganesh BP, Hall A, Ayyaswamy S, Nelson JW, Fultz R, Major A, et al. Diacylglycerol kinase synthesized by commensal Lactobacillus reuteri diminishes protein kinase C phosphorylation and histamine-mediated signaling in the mammalian intestinal epithelium. Mucosal Immunol. 2018;11(2):380\u201393.","journal-title":"Mucosal Immunol"},{"issue":"9","key":"2629_CR127","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1128\/AEM.70.9.5659-5666.2004","volume":"70","author":"J Vulevic","year":"2004","unstructured":"Vulevic J, McCartney AL, Gee JM, Johnson IT, Gibson GR. Microbial species involved in production of 1,2-sn-diacylglycerol and effects of phosphatidylcholine on human fecal microbiota. Appl Environ Microbiol. 2004;70(9):5659\u201366.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"2629_CR128","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/s41467-020-16274-w","volume":"11","author":"EL Johnson","year":"2020","unstructured":"Johnson EL, Heaver SL, Waters JL, Kim BI, Bretin A, Goodman AL, et al. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat Commun. 2020;11(1):2471.","journal-title":"Nat Commun"},{"issue":"1","key":"2629_CR129","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1194\/jlr.RA119000424","volume":"61","author":"C Manca","year":"2020","unstructured":"Manca C, Boubertakh B, Leblanc N, Desch\u00eanes T, Lacroix S, Martin C, et al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J Lipid Res. 2020;61(1):70\u201385.","journal-title":"J Lipid Res"},{"issue":"4","key":"2629_CR130","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461\u201372.","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"2629_CR131","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","volume":"117","author":"J Fu","year":"2015","unstructured":"Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JAM, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117(9):817\u201324.","journal-title":"Circ Res"},{"issue":"8","key":"2629_CR132","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/mnfr.201500014","volume":"59","author":"C Druart","year":"2015","unstructured":"Druart C, Bindels LB, Schmaltz R, Neyrinck AM, Cani PD, Walter J, et al. Ability of the gut microbiota to produce PUFA-derived bacterial metabolites: Proof of concept in germ-free versus conventionalized mice. Mol Nutr Food Res. 2015;59(8):1603\u201313.","journal-title":"Mol Nutr Food Res"},{"issue":"44","key":"2629_CR133","doi-asserted-by":"publisher","first-page":"17808","DOI":"10.1073\/pnas.1312937110","volume":"110","author":"S Kishino","year":"2013","unstructured":"Kishino S, Takeuchi M, Park S-B, Hirata A, Kitamura N, Kunisawa J, et al. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc Natl Acad Sci. 2013;110(44):17808\u201313.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2629_CR134","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1038\/s41467-018-05767-4","volume":"9","author":"A Kindt","year":"2018","unstructured":"Kindt A, Liebisch G, Clavel T, Haller D, H\u00f6rmannsperger G, Yoon H, et al. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nat Commun. 2018;9(1):3760.","journal-title":"Nat Commun"},{"issue":"5","key":"2629_CR135","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1194\/jlr.M002774","volume":"51","author":"VR Velagapudi","year":"2010","unstructured":"Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 2010;51(5):1101\u201312.","journal-title":"J Lipid Res"},{"key":"2629_CR136","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fcimb.2019.00444","volume":"9","author":"M Albouery","year":"2020","unstructured":"Albouery M, Buteau B, Gr\u00e9goire S, Cherbuy C, Pais de Barros JP, Martine L, et al. Age-related changes in the gut microbiota modify brain lipid composition. Frontiers in Cellular and Infection Microbiology. 2020;9:444.","journal-title":"Frontiers in Cellular and Infection Microbiology"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02629-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02629-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02629-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:02:43Z","timestamp":1749193363000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02629-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2629"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02629-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.19.644117","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board Statement: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee Commission d\u2019Ethique Biom\u00e9dicale Hospitalo-facultaire of the Universit\u00e9 catholique de Louvain (Brussel, Belgium). The study was registered at\n                      \n                      \u00a0as trial no. NCT02637115 (protocol code: 2015\/02 JUL\/369, approved on the 13 July 2015). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PDC and AE are inventors on patent applications dealing with the use bacteria on metabolic disorders. PDC was co-founders of The Akkermansia company SA and Enterosys.\u00a0A. E. and P.D.C. are inventors on patent applications dealing with gut microbes in food reward dysregulations. A.E. is inventor on patent applications dealing with the use of bacteria metabolites in the prevention or treatment of respiratory viral infections.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}